logo-loader
viewDirecta Plus PLC

“Grafysorber agreement is the cornerstone of our efforts to grow", says Directa Plus's Cesareo

Directa Plus will work with Italian firm Sartec to develop a commercial-scale industrial system based on the use of Grafysorber

On world water day, Giulio Cesareo, chief executive of Directa Plus Plc (LON:DCTA), tells Proactive why Grafysorber, a graphene-based product for treating oil-contaminants, is a ground-breaking product.

Directa Plus will work with Italian firm Sartec to develop a commercial-scale industrial system based on the use of Grafysorber.

“The commercial agreement we signed yesterday is really significant, it’s the cornerstone of our efforts to grow Directa Plus,” said Cesareo. He added: “After eight months of intense testing with Sartec we are now talking about a strong commercial agreement.”

Quick facts: Directa Plus PLC

Price: 73 GBX

AIM:DCTA
Market: AIM
Market Cap: £44.53 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Directa Plus PLC named herein, including the promotion by the Company of Directa Plus PLC in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Investor Update: DeepMatter to collaborate with AstraZeneca

Headlines from the Proactive UK newsroom. DeepMatter (LON:DMTR) has agreed a tie-up with AstraZeneca to combine their drug development technology platforms. Deepmatter uses AI to monitor and record chemical reactions during drug development. Rare disease database group Open Orphan...

3 days, 13 hours ago

2 min read